Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 1, 2010, Pages 30-36

  Selleng, S ^a   Malowsky, B ^b   Strobel, U ^a   Wessel, A ^a   Ittermann, T ^a   Wollert, H G ^b   Warkentin, T E ^c   Greinacher, A ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b Herz und Diabeteszentrum Mecklenburg/Vorpommern   (Germany)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

Cardiopulmonary bypass; Diagnosis; Heparin induced thrombocytopenia; Platelets

Indexed keywords

CERTOPARIN; HEPARIN; IMMUNOGLOBULIN G; MONOEMBOLEX; PHENPROCOUMON; THROMBOCYTE ANTIBODY; THROMBOCYTE FACTOR 4; THROMBOPLASTIN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BODY MASS; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; EXTRACORPOREAL CIRCULATION; FEMALE; HEART SURGERY; HEART VALVE REPLACEMENT; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PREDICTION; PRIORITY JOURNAL; SEROCONVERSION; SURGICAL PATIENT; SURGICAL TECHNIQUE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

AGED; ANTIBODIES; ANTICOAGULANTS; BLOOD PLATELETS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FEMALE; HEPARIN; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; LOGISTIC MODELS; MALE; ODDS RATIO; PLATELET ACTIVATION; PLATELET COUNT; PLATELET FACTOR 4; POSTOPERATIVE CARE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THROMBOCYTOPENIA; TIME FACTORS;

EID: 73049094086     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03626.x     Document Type: Article

References (19)

1. Warkentin TE, Warkentin TE, Greinacher A. Clinical picture of heparin-induced thrombocytopenia. Heparin-induced Thrombocytopenia 2007, 21-66. In, eds, New York, Informa Healthcare
2. Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133:340S-80S.
3. Nader ND, Khadra WZ, Reich NT, Bacon DR, Salerno TA, Panos AL. Blood product use in cardiac revascularization: comparison of on- and off-pump techniques. Ann Thorac Surg 1999, 68:1640-3.
4. Bauer TL, Arepally G, Konkle BA, Mestichelli B, Shapiro SS, Cines DB, Poncz M, McNulty S, Amiral J, Hauck WW, Edie RN, Mannion JD. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 1997, 95:1242-6.
5. Pouplard C, May MA, Iochmann S, Amiral J, Vissac AM, Marchand M, Gruel Y. Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin: clinical implications for heparin-induced thrombocytopenia. Circulation 1999, 99:2530-6.
6. Schallmoser K, Drexler C, Rohde E, Strunk D, Groselj-Strele A, Lanzer G, Kroll H, Panzer S. The particle gel immunoassay as a rapid test to rule out heparin-induced thrombocytopenia? J Thorac Cardiovasc Surg 2009, 137:781-3.
7. Visentin GP, Malik M, Cyganiak KA, Aster RH. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes. J Lab Clin Med 1996, 128:376-83.
8. Warkentin TE, Sheppard JA, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 2000, 96:1703-8.
9. Pouplard C, May MA, Regina S, Marchand M, Fusciardi J, Gruel Y. Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies. Br J Haematol 2005, 128:837-41.
10. Warkentin TE, Crowther MA. When is HIT really HIT? Ann Thorac Surg 2007, 83:21-3.
11. Juhl D, Eichler P, Lubenow N, Strobel U, Wessel A, Greinacher A. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia. Eur J Haematol 2006, 76:420-6.
12. Warkentin TE, Roberts RS, Hirsh J, Kelton JG. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med 2003, 163:2518-24.
13. Lillo-Le Louet A, Boutouyrie P, Alhenc-Gelas M, Le Beller C, Gautier I, Aiach M, Lasne D. Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass. J Thromb Haemost 2004, 2:1882-8.
14. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999, 16:9-13.
15. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006, 4:759-65.
16. Selleng S, Selleng K, Wollert HG, Müllejans B, Lietz T, Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass. J Thromb Haemost 2008, 6:428-35.
17. Greinacher A, Warkentin TE, Warkentin TE, Greinacher A. Treatment of heparin-induced thrombocytopenia: an overview. Heparin-induced Thrombocytopenia 2007, 283-317. In, eds, New York, Informa Healthcare
18. Tardy B, Lecompte T, Boelhen F, Tardy-Poncet B, Elalamy I, Morange P, Gruel Y, Wolf M, Francois D, Racadot E, Camarasa P, Blouch MT, Nguyen F, Doubine S, Dutrillaux F, Alhenc-Gelas M, Martin-Toutain I, Bauters A, Ffrench P, de Maistre E. Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin. Blood 2006, 108:1492-6.
19. Mattioli AV, Bonetti L, Zennaro M, Ambrosio G, Mattioli G. Heparin/PF4 antibodies formation after heparin treatment: temporal aspects and long-term follow-up. Am Heart J 2009, 157:589-95.